1. Home
  2. FLNC vs IMCR Comparison

FLNC vs IMCR Comparison

Compare FLNC & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluence Energy Inc.

FLNC

Fluence Energy Inc.

N/A

Current Price

$16.21

Market Cap

2.2B

Sector

Miscellaneous

ML Signal

N/A

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

N/A

Current Price

$29.94

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLNC
IMCR
Founded
2018
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.7B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
FLNC
IMCR
Price
$16.21
$29.94
Analyst Decision
Hold
Buy
Analyst Count
18
12
Target Price
$16.93
$61.82
AVG Volume (30 Days)
3.5M
358.3K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.39
EPS
N/A
N/A
Revenue
$2,262,830,000.00
$249,428,000.00
Revenue This Year
$51.18
$14.57
Revenue Next Year
$21.37
$8.21
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.05
52 Week Low
$3.46
$23.15
52 Week High
$33.51
$40.71

Technical Indicators

Market Signals
Indicator
FLNC
IMCR
Relative Strength Index (RSI) 44.78 37.21
Support Level $13.92 N/A
Resistance Level $18.21 $34.35
Average True Range (ATR) 0.99 1.28
MACD 0.24 -0.18
Stochastic Oscillator 42.01 15.72

Price Performance

Historical Comparison
FLNC
IMCR

About FLNC Fluence Energy Inc.

Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: